Who knows the role of e-commerce in the medical circulation supply system?

E-commerce has been widely used in the medical circulation guarantee system. With the acceleration of China's medical and health system reform, it will surely become an inevitable choice for pharmaceutical enterprises to cope with fierce market competition. However, the development of medical e-commerce in China is in the primary stage, and there are still many shortcomings. To solve the problem of "difficult and expensive medical treatment", the medical circulation and supply system is one of the key factors, and the construction of medical e-commerce platform should be improved as soon as possible. It is a better way to reduce medical expenses to establish an e-commerce platform for pharmaceutical circulation and supply system and introduce a third-party mechanism.

First, the development status of e-commerce in the pharmaceutical circulation and supply system

In recent years, e-commerce has been widely used in the field of drug circulation. With the acceleration of informatization process, informatization will surely become the development trend of pharmaceutical industry. Developing pharmaceutical e-commerce is not only the inherent requirement of the reform of pharmaceutical circulation system, but also the inevitable choice for pharmaceutical enterprises to cope with domestic and foreign competition. Medical e-commerce is a safe, reliable, open and easy-to-maintain electronic commerce platform for medical trade, with medical institutions, pharmaceutical companies, banks, pharmaceutical production units, medical information service providers and insurance companies as network members. Medical e-commerce mainly includes B2B, B2C and medical e-commerce platforms.

The information revealed by the first "Internet Drug Information and Trading Service Summit Forum": As of June 18, 2007, there were *** 1 178 enterprises, accounting for 50.09% of the applicants, including 385 operating enterprises and 793 non-operating enterprises. As of June 26th, 2007, nine enterprises in China have obtained the Qualification Certificate of Internet Drug Trading Service, including five third-party platforms and four B2C business models (only operating OTC). No enterprise in B2B business model has obtained the certificate. It should be noted that many documents are now talking about the medical B2B model. In fact, the so-called B2B in China is traded through the medical e-commerce platform, which is not a B2B model in a strict sense. The medical websites in China are still at two lower levels: publishing and obtaining medical information through the Internet, and publishing and matching drug price information. There are few complete e-commerce services (generally considered to be complete e-commerce, that is, the whole process from publishing and obtaining drug information to online trading and online payment is completed through the Internet. It covers a series of links such as bidding, information consultation, investment promotion agency, wholesale circulation and so on. ), there is no mature third-party-based medical e-commerce trading and service platform.